CDKN2A and neoplasm: To our knowledge, the present work is the first to report that p16Ink4a and p21Cip1/Waf1 CDK inhibitors, which are considered cell-intrinsic tumour suppressors, in fact promote tumour development, as demonstrated in the present allograft mouse model.